Search Results

Search Results for "transvaginal mesh"


  • Another legal decision against Ethicon
    A judge recently ordered Johnson & Johnson’s Ethicon division to pay Irish health care products manufacturer Covidien $176.5 million in damages over a patent dispute, Bloomberg reports. At the conclusion of a non-jury trial, U.S. District Judge Janet Bond Arterton in New Haven, Conn., ruled th...
  • Tests evaluate urinary incontinence
    Urinary incontinence can have a number of causes, according to the Mayo Clinic. They run the gamut from temporary causes, such as medication or overhydration; to relatively minor conditions such as urinary tract infection; to relatively serious causes such as bladder cancer. A number of tests are av...
  • Investors cautioned about J&J stock
    In a piece for investing blog Seeking Alpha, contributor Sarah Maller discusses her reasons for giving up on health care giant Johnson & Johnson as a viable investment. “Manufacturing problems and recalls are not just embarrassing,” she writes, “but they are a worrisome sign that managemen...
  • Bonuses cut for executives at troubled J&J
    According to a story on the Huffington Post, Johnson & Johnson has lowered its planned bonuses for the company’s top executives by 10 percent. A statement from the company acknowledges “disappointments” from 2012, and resultant damage to the company’s public reputation. Johnson & Joh...
  • Buffett sours on Johnson & Johnson
    Health care giant Johnson & Johnson’s legal troubles are apparently giving investor Warren Buffett pause, according to a blog item for the Philadelphia Inquirer. Buffett recently released his annual letter to shareholders of Berkshire Hathaway, and it shows that Berkshire had dropped its holdi...
  • Diabetes drug could be a ‘blockbuster’
    A blog post on Forbes deals with Johnson & Johnson’s type 2 diabetes drug Canagliflozin, which is expected to receive FDA approval soon and which the report describes as having “blockbuster potential.” According to the report, Canagliflozin proved effective at lowering blood glucose levels...
  • J&J must pay $181M as part of Medicare fraud case
    Johnson & Johnson has been ordered to pay $181 million to a Houston law firm that worked on behalf of the state of Arkansas in a Medicare fraud case against the company. A Reuters story says that payment is part of a $1.2 billion settlement the company agreed to pay Arkansas in 2012, based on th...
  • Government investigating J&J over medical devices
    Johnson & Johnson has disclosed that the government is investigating possible false claims connected to two of the company’s medical devices, Bloomberg reports. The ASR artificial hip implant, manufactured by Johnson & Johnson subsidiary DePuy Orthopaedics, has been the basis of about 10,0...
  • Prepare for doctor’s questions about incontinence
    When you’re getting treatment for urinary incontinence, your doctor is likely to ask you a series of questions, according to the Mayo Clinic. The clinic has compiled a list of those probable questions, so patients can be prepared for them and have their answers ready. The Clinic acknowledges that ...
  • Senators seek to ban ‘pay for delay’
    In a bipartisan effort, U.S. Senators have reintroduced legislation banning a pharmaceutical industry practice that keeps lower-cost medications away from patients who need them. The practice, commonly called “pay for delay,” occurs when one drug company pays another to delay introducing a less-...
Page 10 of 21 «...89101112...»